Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amanda Rupert"'
Autor:
Katie Nagle, Kimberly Sprott, Tracey Reeser, Jill Swinning, Marsha Farley, Rachel Sherman, Amanda Rupert, Lindsay Castle, Naveen Saha, Rodolfo Jose Denadai Benatti, Katherine Dodd, Anish Amin, Sreedhar Billakanty, Anupam Basuray
Publikováno v:
Journal of Cardiac Failure. 29:705-706
Autor:
Svetlana Lima, Amanda Rupert, Wenbing Jin, Monica Viladomiu, Silvia Pires, Viola Woo, Gregory Putzel, Andrew Marderstein, Gabriela Funez-dePagnier1, Wei Yang, Chun-Jun Guo, Ellen Scherl, Randy Longman
Publikováno v:
Gastroenterology. 164:S93
Joint inflammation, or spondyloarthritis (SpA), is the most common extra-intestinal manifestation of inflammatory bowel disease (IBD), but the specific role for therapies targeting SpA is not well defined. One of the earliest medications used for the
Autor:
Amanda Rupert, Shireen Pais
Publikováno v:
American Journal of Gastroenterology. 117:e1235-e1236
Publikováno v:
American Journal of Gastroenterology. 117:e1757-e1757
Autor:
Svetlana Ferreira Lima, Amanda Rupert, Monica Viladomiu, Andrew Marderstein, Silvia Pires, Gregory Putzel, Viola Woo, Gabriela Funez-dePagnier, Wen-Bing Jin, Chun-Jun Guo, Ellen Scherl, Randy S. Longman
Publikováno v:
The Journal of Immunology. 208:174.01-174.01
Joint inflammation (spondyloarthritis, SpA), is the most common extra-intestinal manifestation of inflammatory bowel disease (IBD), but the specific role for therapies targeting SpA is not well defined. Sulfasalazine (SAS) is a prodrug composed of tw
Autor:
Svetlana Ferreira Lima, Randy Longman, Amanda Rupert, Monica Viladomiu, Andrew Marderstein, Gregory Putzel, Gabriela Funez-dePagnier, Viola Woo, Maeva L Metz, Ellen J Scherl, Lance Chou
Publikováno v:
The Journal of Immunology. 204:237.8-237.8
Spondyloarthritis (SpA) is the most common extra-intestinal manifestation of inflammatory bowel disease (IBD). Sulfasalazine (SAS) is one of the earliest medications used in IBD and its efficacy in spondyloarthritis is thought to depend on its antiba
Autor:
Yecheskel Schneider, Shirley Cohen-Mekelburg, Ellen Scherl, Alec Faggen, Brian P. Bosworth, Stephanie Gold, Adam F. Steinlauf, Nicole T. Shen, Amanda Rupert
Publikováno v:
Inflammatory bowel diseases. 23(10)
Background Infliximab (IFX) is commonly used in patients with inflammatory bowel disease. One common side effect of IFX is an acute infusion reaction. Despite the lack of evidence supporting their use, clinicians use various premedications to prevent
Autor:
Yecheskel Schneider, Brian P. Bosworth, Amanda Rupert, Stephanie Gold, Adam F. Steinlauf, Ellen Scherl, Alec Faggen, Nicole T. Shen, Shirley Cohen-Mekelburg
Publikováno v:
Gastroenterology. 152:S792-S793
Autor:
Adam F. Steinlauf, Stephanie Gold, Shirley Cohen-Mekelburg, Ellen Scherl, Yecheskel Schneider, Brian P. Bosworth, Amanda Rupert, Alec Faggen, Nicole T. Shen
Publikováno v:
Gastroenterology. 152:S584-S585